Skip to main content
OFIX
NASDAQ Manufacturing

10% Owner Juniper Sells $2.7M of Orthofix Stock in Two Days

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.98
Mkt Cap
$365.779M
52W Low
$8.5
52W High
$16.99
52W Position info
5.6% above low
Off High info
47% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

OFIX is trading near its 52-week low of $8.5 (5.6% above the low).

Summary

10% owner Juniper Investment Company sold $2.73 million of Orthofix stock in two open-market transactions on September 18 and 21, following a smaller sale in August.


Key Events · Ownership and Investor Activity · OFIX

  • 10% Owner Sells $2.73M

    Juniper Investment Company sold 310,000 shares for $2,732,097 in two open-market transactions on September 18 and 21 at prices ranging from $8.63 to $8.98.

  • Stake Reduced to 3.77M Shares

    Post-transaction holdings in Juniper Targeted Opportunity Fund, L.P. stand at 3,771,216 shares, down from 4,081,216 before the sales.

  • Follows August Sale

    This follows a prior $402,744 sale by the same 10% owner disclosed on August 18, 2026, indicating continued distribution.

  • Context: Strong Q2 and CMS Reversal

    The sales come after Orthofix reported Q2 net sales of $210.9M (up 5% pro forma constant currency) and raised full-year guidance, and after CMS restored Medicare reimbursement for bone growth stimulators.


Analysis · OFIX · Manufacturing

A significant distribution by a financial investor warrants attention: Juniper Investment Company, a 10% owner, sold 310,000 shares for $2.73 million across two open-market transactions on September 18 and 21. This follows a smaller $402,744 sale in August. The sale represents roughly 0.75% of the company's market cap and reduces Juniper's stake in the Targeted Opportunity Fund to 3,771,216 shares. While 10% owners often sell for portfolio rebalancing rather than fundamental reasons, the size and timing — just weeks after strong Q2 results and a CMS reimbursement reversal — raise questions.

How filings like this one have moved

In the 30 days to Oct 16, 2026, 29.4% of the 1487 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OFIX was trading at $8.98 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $365.8M. The 52-week trading range was $8.50 to $16.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OFIX - Latest Insights

OFIX
Sep 23, 2026, 3:52 PM EDT
Filing Type: 4/A
Importance Score:
7
Price at Filing: $9.11
Real-time Price: $9.36 info
Change: +$0.250 (+3%) info
Market Cap: $381.257M info
OFIX
Aug 05, 2026, 7:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.37
Real-time Price: $9.36 info
Change: -$4.01 (-30%) info
Market Cap: $381.257M info
OFIX
Aug 05, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $13.37
Real-time Price: $9.36 info
Change: -$4.01 (-30%) info
Market Cap: $381.257M info
OFIX
Jul 02, 2026, 4:29 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $10.80
Real-time Price: $9.36 info
Change: -$1.44 (-13%) info
Market Cap: $381.257M info
OFIX
Jul 02, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.94
Real-time Price: $9.36 info
Change: -$0.580 (-6%) info
Market Cap: $381.257M info